Louis-Armstrong

Nuclear Medicine/ Radiopharmaceuticals Market 2020 | Industry Trends, Growth Drivers, Competitive Landscape, Regional Analysis 2026

The MarketWatch News Department was not involved in the creation of this content.

Dec 04, 2020 (The Expresswire) —
The global “Nuclear Medicine/Radiopharmaceuticals Market” size is projected to reach USD 9.67 billion by 2026. According to a report published by Fortune Business Insights, titled “Nuclear Medicine/Radiopharmaceuticals Market Size, Share and Industry Analysis, By Type (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End User (Hospitals and Clinics, Diagnostic Centres, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 4.86 billion in 2018. Driven by increasing number of successful clinical trials, the market will exhibit a CAGR of 9.2% from 2019-2026.

Leading Players operating in the Nuclear Medicine/ Radiopharmaceuticals Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Lantheus Medical Imaging, Inc.

  • Cardinal Health

  • Norgine B.V.

  • Curium

  • Advanced Accelerator Applications (Novartis AG)

  • Bracco Diagnostic Inc.

  • Jubilant Life Sciences Limited

  • Bayer AG

  • Eli Lilly and Company

  • GE Healthcare (General Electric Company)

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nuclear-medicine-radiopharmaceuticals-market-101812

Radiopharmaceuticals are substances that are used to diagnose specific medical problems or diseases. Increasing imaging capabilities and efficiencies have led to a wide product adoption across the world. Increasing number of successful clinical trials associated with radiopharmaceuticals will fuel the demand for the product. Recent drug application area discoveries have showcased promise for the companies operating in the market. Technological advancements in nuclear imaging and their applications in diagnosis of cancer and other serious diseases have opened up a huge potential for growth. Growing awareness regarding the adverse effects of chronic diseases, and the need for early diagnosis will aid market growth.

The advancements in imaging systems have played a major role in the growth of the market. Companies are putting in increased efforts towards the manufacturing of diagnostic radiopharmaceuticals. Increasing investments in the research and development (RandD) will create several growth opportunities for market growth. At the same instance, therapeutic radiopharmaceuticals can be used for the treatment of critical illnesses such as cancers.

Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nuclear-medicine-radiopharmaceuticals-market-101812

Detailed Table of Content:

  • Introduction

    • Research Scope

    • Market Segmentation

    • Research Methodology

    • Definitions and Assumptions

  • Executive Summary

  • Market Dynamics

    • Market Drivers

    • Market Restraints

    • Market Opportunities

  • Key Insights

    • Installed Base of PET/PET-CT Scanners For Key Countries, 2015 and 2018

    • Installed Base of Gamma Cameras for Key Countries, 2018

    • PET/PET-CT Procedure Volume for Key Countries, 2018

    • Reimbursement Scenario in Key Countries

    • New Product Launches

    • Key Industry Developments

    • Pipeline Analysis

  • Global Nuclear Medicine/ Radiopharmaceuticals Market Analysis, Insights and Forecast, 2015-2026

    • Key Findings / Summary

    • Market Analysis, Insights and Forecast By Type

      • Diagnostic Radiopharmaceuticals

        • PET Radiopharmaceuticals

          • FDG-PET/18F

          • 68Ga

          • 68Cu

          • 11C

          • Others

        • SPECT Radiopharmaceuticals

          • Technetium-99m

          • Iodine-123

          • Xenon-133

          • Thallium-201

          • Others

        • Therapeutic Radiopharmaceuticals

      • Market Analysis, Insights and Forecast By Application

        • Neurology

        • Cardiology

        • Oncology

        • Others

      • Market Analysis, Insights and Forecast By End User

        • Hospitals and Clinics

        • Diagnostic Centers

        • Others

      • Market Analysis, Insights and Forecast By Region

        • North America

        • Europe

        • Asia Pacific

        • Rest of the World

Reasons to Purchase this Report:

  • Comprehensive analysis of the Nuclear Medicine/ Radiopharmaceuticals Market growth drivers, obstacles, opportunities, and other related challenges.

  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.

  • Identifies market restraints and boosters.

  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/nuclear-medicine-radiopharmaceuticals-market-101812

KEY QUESTIONS ANSWERED:

  • What are the key technological and Nuclear Medicine/ Radiopharmaceuticals Market trends shaping the market?

  • What are the key opportunities in the market?

  • What are the key companies operating in the market?

  • Which company accounted for the highest market share?

  • Why Choose Fortune Business Insights?

  • What is the market size and growth rate of the global and regional market by various segments?

  • What is the market size and growth rate of the market for selective countries?

  • Which region or sub-segment is expected to drive the market in the forecast period?

  • What Factors are estimated to drive and restrain the Nuclear Medicine/ Radiopharmaceuticals Market growth?

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin|Twitter|BLogs

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Nuclear Medicine/ Radiopharmaceuticals Market 2020 | Industry Trends, Growth Drivers, Competitive Landscape, Regional Analysis 2026

COMTEX_375516499/2598/2020-12-04T00:57:38

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article